Charles Mc Wherter, Ph.D.
About Charles Mc Wherter, Ph.D.
Charles McWherter: Chief Scientific Officer and President of Research and Development
Charles McWherter currently holds the positions of Chief Scientific Officer and President of Research and Development. In these roles, he is responsible for overseeing the scientific direction and research initiatives within the organization. His leadership and vision play a significant role in shaping the company's innovation strategies and development pipelines.
Charles McWherter's Educational Background
Charles McWherter earned a Ph.D. in Biophysical Chemistry from Cornell University. His advanced studies in this field equipped him with deep expertise in the chemistry and physics of biological systems, which serves as a foundation for his extensive career in scientific research and development.
Charles McWherter's Experience as Visiting Scientist at Weizmann Institute of Science
Charles McWherter spent part of his academic and early professional career as a Visiting Scientist at the Weizmann Institute of Science in Israel. This experience provided him the opportunity to collaborate with leading researchers and further develop his expertise in biophysical chemistry.
Charles McWherter's Tenure at Pfizer Inc.
From 2003 to 2007, Charles McWherter served as the Vice President and head of the cardiovascular therapeutic area at Pfizer Inc. In this role, he led efforts to advance cardiovascular drug development and contributed to the overall strategic direction of Pfizer's cardiovascular research programs.
Charles McWherter's Role at Sugen, Inc.
Before his tenure at Pfizer Inc., Charles McWherter was the Vice President of Drug Discovery at Sugen, Inc., from 2001 to 2003. Sugen, Inc., a subsidiary of Pharmacia acquired by Pfizer, was known for its pioneering work in targeted cancer therapies. During his time there, McWherter was instrumental in driving the company’s drug discovery initiatives.